Human Vaccine Adjuvants Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Type (Adjuvant Emulsion, Particulate Adjuvants, Combination Adjuvants, and Others); Route of Administration (Oral, Intradermal, Intranasal, Intramuscular, and Others); Application (Research Applications, and Commercial Applications), Geography

Report Code: TIPRE00020517 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

A human vaccine adjuvant is explained as any substance that facilitates, extends, or elevates antigen-specific immune responses when used in conjunction with a specific vaccine immunogen. The sole vaccine adjuvants presently licensed by the FDA are aluminum salts. The remaining other adjuvants are viewed in experimental and are undergoing certain preclinical testing. Some complications with the development of adjuvants include confined adjuvanticity of specific formulations to a few antigens, utilization of aluminum adjuvants as reference adjuvant preparations under poor conditions, use of sub-standard assays failing to assure formulations to show adjuvanticity in clinical trials.
MARKET DYNAMIC
Factors driving the growth of the human vaccine adjuvants market are a surge in adjuvant use in vaccines, rising focus on immunization programs from various government bodies, and technological advancements in aluminum hydroxide-based adjuvants. However, a rigid regulatory environment and time-consuming approvals are likely to hamper the growth of the market. Moreover, combination adjuvants, pandemic diseases are further expected to create growth opportunities in the market.

MARKET SCOPE

The "Human Vaccine Adjuvants Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of human vaccines adjuvants market with detailed market segmentation by type of market, route of administration, and application. The human vaccines adjuvants market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in human vaccines adjuvants market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The human vaccine adjuvants market is segmented on the basis of market type, route of administration, and application. On the basis of market type, the market is categorized as adjuvant emulsion, particulate adjuvants, combination adjuvants, and others. On the basis of route of administration, the market is categorized as oral, intradermal, intranasal, intramuscular and others. On the basis of application, the market is categorized as research applications, and commercial applications.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the human vaccine adjuvants market based on various segments. It also provides market size and forecast estimates from year 2018 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The human vaccine adjuvants market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting human vaccines adjuvants market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the human vaccines adjuvants market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the human vaccine adjuvants market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from human vaccines adjuvants market are anticipated to have lucrative growth opportunities in the future with the rising demand for viral vaccines in the global market. Below mentioned is the list of few companies engaged in the human vaccine adjuvants market.

The report also includes the profiles of key players in human vaccines adjuvants market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years.

  •   GSK
  •   CSL Limited
  •   Brenntag Biosector
  •   SEPPIC
  •   SPI Pharma
  •   Novavax
  •   Avanti Polar Lipids
  •   Aphios Corporation
  •   Agenus
  •   Merck KGaA
  •   Invivogen

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Human Vaccine Adjuvants Market - By Type
1.3.2 Human Vaccine Adjuvants Market - By Route of Administration
1.3.3 Human Vaccine Adjuvants Market - By Application
1.3.4 Human Vaccine Adjuvants Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. HUMAN VACCINE ADJUVANTS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. HUMAN VACCINE ADJUVANTS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. HUMAN VACCINE ADJUVANTS MARKET - GLOBAL MARKET ANALYSIS
6.1. HUMAN VACCINE ADJUVANTS - GLOBAL MARKET OVERVIEW
6.2. HUMAN VACCINE ADJUVANTS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. HUMAN VACCINE ADJUVANTS MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. ADJUVANT EMULSION
7.3.1. Overview
7.3.2. Adjuvant Emulsion Market Forecast and Analysis
7.4. PARTICULATE ADJUVANTS
7.4.1. Overview
7.4.2. Particulate Adjuvants Market Forecast and Analysis
7.5. COMBINATION ADJUVANTS
7.5.1. Overview
7.5.2. Combination Adjuvants Market Forecast and Analysis
7.6. OTHERS
7.6.1. Overview
7.6.2. Others Market Forecast and Analysis
8. HUMAN VACCINE ADJUVANTS MARKET - REVENUE AND FORECASTS TO 2028 - ROUTE OF ADMINISTRATION
8.1. OVERVIEW
8.2. ROUTE OF ADMINISTRATION MARKET FORECASTS AND ANALYSIS
8.3. ORAL
8.3.1. Overview
8.3.2. Oral Market Forecast and Analysis
8.4. INTRADERMAL
8.4.1. Overview
8.4.2. Intradermal Market Forecast and Analysis
8.5. INTRANASAL
8.5.1. Overview
8.5.2. Intranasal Market Forecast and Analysis
8.6. INTRAMUSCULAR
8.6.1. Overview
8.6.2. Intramuscular Market Forecast and Analysis
8.7. OTHERS
8.7.1. Overview
8.7.2. Others Market Forecast and Analysis
9. HUMAN VACCINE ADJUVANTS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
9.1. OVERVIEW
9.2. APPLICATION MARKET FORECASTS AND ANALYSIS
9.3. RESEARCH APPLICATIONS
9.3.1. Overview
9.3.2. Research Applications Market Forecast and Analysis
9.4. COMMERCIAL APPLICATIONS
9.4.1. Overview
9.4.2. Commercial Applications Market Forecast and Analysis
10. HUMAN VACCINE ADJUVANTS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Human Vaccine Adjuvants Market Overview
10.1.2 North America Human Vaccine Adjuvants Market Forecasts and Analysis
10.1.3 North America Human Vaccine Adjuvants Market Forecasts and Analysis - By Type
10.1.4 North America Human Vaccine Adjuvants Market Forecasts and Analysis - By Route of Administration
10.1.5 North America Human Vaccine Adjuvants Market Forecasts and Analysis - By Application
10.1.6 North America Human Vaccine Adjuvants Market Forecasts and Analysis - By Countries
10.1.6.1 United States Human Vaccine Adjuvants Market
10.1.6.1.1 United States Human Vaccine Adjuvants Market by Type
10.1.6.1.2 United States Human Vaccine Adjuvants Market by Route of Administration
10.1.6.1.3 United States Human Vaccine Adjuvants Market by Application
10.1.6.2 Canada Human Vaccine Adjuvants Market
10.1.6.2.1 Canada Human Vaccine Adjuvants Market by Type
10.1.6.2.2 Canada Human Vaccine Adjuvants Market by Route of Administration
10.1.6.2.3 Canada Human Vaccine Adjuvants Market by Application
10.1.6.3 Mexico Human Vaccine Adjuvants Market
10.1.6.3.1 Mexico Human Vaccine Adjuvants Market by Type
10.1.6.3.2 Mexico Human Vaccine Adjuvants Market by Route of Administration
10.1.6.3.3 Mexico Human Vaccine Adjuvants Market by Application
10.2. EUROPE
10.2.1 Europe Human Vaccine Adjuvants Market Overview
10.2.2 Europe Human Vaccine Adjuvants Market Forecasts and Analysis
10.2.3 Europe Human Vaccine Adjuvants Market Forecasts and Analysis - By Type
10.2.4 Europe Human Vaccine Adjuvants Market Forecasts and Analysis - By Route of Administration
10.2.5 Europe Human Vaccine Adjuvants Market Forecasts and Analysis - By Application
10.2.6 Europe Human Vaccine Adjuvants Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Human Vaccine Adjuvants Market
10.2.6.1.1 Germany Human Vaccine Adjuvants Market by Type
10.2.6.1.2 Germany Human Vaccine Adjuvants Market by Route of Administration
10.2.6.1.3 Germany Human Vaccine Adjuvants Market by Application
10.2.6.2 France Human Vaccine Adjuvants Market
10.2.6.2.1 France Human Vaccine Adjuvants Market by Type
10.2.6.2.2 France Human Vaccine Adjuvants Market by Route of Administration
10.2.6.2.3 France Human Vaccine Adjuvants Market by Application
10.2.6.3 Italy Human Vaccine Adjuvants Market
10.2.6.3.1 Italy Human Vaccine Adjuvants Market by Type
10.2.6.3.2 Italy Human Vaccine Adjuvants Market by Route of Administration
10.2.6.3.3 Italy Human Vaccine Adjuvants Market by Application
10.2.6.4 Spain Human Vaccine Adjuvants Market
10.2.6.4.1 Spain Human Vaccine Adjuvants Market by Type
10.2.6.4.2 Spain Human Vaccine Adjuvants Market by Route of Administration
10.2.6.4.3 Spain Human Vaccine Adjuvants Market by Application
10.2.6.5 United Kingdom Human Vaccine Adjuvants Market
10.2.6.5.1 United Kingdom Human Vaccine Adjuvants Market by Type
10.2.6.5.2 United Kingdom Human Vaccine Adjuvants Market by Route of Administration
10.2.6.5.3 United Kingdom Human Vaccine Adjuvants Market by Application
10.2.6.6 Rest of Europe Human Vaccine Adjuvants Market
10.2.6.6.1 Rest of Europe Human Vaccine Adjuvants Market by Type
10.2.6.6.2 Rest of Europe Human Vaccine Adjuvants Market by Route of Administration
10.2.6.6.3 Rest of Europe Human Vaccine Adjuvants Market by Application
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Human Vaccine Adjuvants Market Overview
10.3.2 Asia-Pacific Human Vaccine Adjuvants Market Forecasts and Analysis
10.3.3 Asia-Pacific Human Vaccine Adjuvants Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Human Vaccine Adjuvants Market Forecasts and Analysis - By Route of Administration
10.3.5 Asia-Pacific Human Vaccine Adjuvants Market Forecasts and Analysis - By Application
10.3.6 Asia-Pacific Human Vaccine Adjuvants Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Human Vaccine Adjuvants Market
10.3.6.1.1 Australia Human Vaccine Adjuvants Market by Type
10.3.6.1.2 Australia Human Vaccine Adjuvants Market by Route of Administration
10.3.6.1.3 Australia Human Vaccine Adjuvants Market by Application
10.3.6.2 China Human Vaccine Adjuvants Market
10.3.6.2.1 China Human Vaccine Adjuvants Market by Type
10.3.6.2.2 China Human Vaccine Adjuvants Market by Route of Administration
10.3.6.2.3 China Human Vaccine Adjuvants Market by Application
10.3.6.3 India Human Vaccine Adjuvants Market
10.3.6.3.1 India Human Vaccine Adjuvants Market by Type
10.3.6.3.2 India Human Vaccine Adjuvants Market by Route of Administration
10.3.6.3.3 India Human Vaccine Adjuvants Market by Application
10.3.6.4 Japan Human Vaccine Adjuvants Market
10.3.6.4.1 Japan Human Vaccine Adjuvants Market by Type
10.3.6.4.2 Japan Human Vaccine Adjuvants Market by Route of Administration
10.3.6.4.3 Japan Human Vaccine Adjuvants Market by Application
10.3.6.5 South Korea Human Vaccine Adjuvants Market
10.3.6.5.1 South Korea Human Vaccine Adjuvants Market by Type
10.3.6.5.2 South Korea Human Vaccine Adjuvants Market by Route of Administration
10.3.6.5.3 South Korea Human Vaccine Adjuvants Market by Application
10.3.6.6 Rest of Asia-Pacific Human Vaccine Adjuvants Market
10.3.6.6.1 Rest of Asia-Pacific Human Vaccine Adjuvants Market by Type
10.3.6.6.2 Rest of Asia-Pacific Human Vaccine Adjuvants Market by Route of Administration
10.3.6.6.3 Rest of Asia-Pacific Human Vaccine Adjuvants Market by Application
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Human Vaccine Adjuvants Market Overview
10.4.2 Middle East and Africa Human Vaccine Adjuvants Market Forecasts and Analysis
10.4.3 Middle East and Africa Human Vaccine Adjuvants Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Human Vaccine Adjuvants Market Forecasts and Analysis - By Route of Administration
10.4.5 Middle East and Africa Human Vaccine Adjuvants Market Forecasts and Analysis - By Application
10.4.6 Middle East and Africa Human Vaccine Adjuvants Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Human Vaccine Adjuvants Market
10.4.6.1.1 South Africa Human Vaccine Adjuvants Market by Type
10.4.6.1.2 South Africa Human Vaccine Adjuvants Market by Route of Administration
10.4.6.1.3 South Africa Human Vaccine Adjuvants Market by Application
10.4.6.2 Saudi Arabia Human Vaccine Adjuvants Market
10.4.6.2.1 Saudi Arabia Human Vaccine Adjuvants Market by Type
10.4.6.2.2 Saudi Arabia Human Vaccine Adjuvants Market by Route of Administration
10.4.6.2.3 Saudi Arabia Human Vaccine Adjuvants Market by Application
10.4.6.3 U.A.E Human Vaccine Adjuvants Market
10.4.6.3.1 U.A.E Human Vaccine Adjuvants Market by Type
10.4.6.3.2 U.A.E Human Vaccine Adjuvants Market by Route of Administration
10.4.6.3.3 U.A.E Human Vaccine Adjuvants Market by Application
10.4.6.4 Rest of Middle East and Africa Human Vaccine Adjuvants Market
10.4.6.4.1 Rest of Middle East and Africa Human Vaccine Adjuvants Market by Type
10.4.6.4.2 Rest of Middle East and Africa Human Vaccine Adjuvants Market by Route of Administration
10.4.6.4.3 Rest of Middle East and Africa Human Vaccine Adjuvants Market by Application
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Human Vaccine Adjuvants Market Overview
10.5.2 South and Central America Human Vaccine Adjuvants Market Forecasts and Analysis
10.5.3 South and Central America Human Vaccine Adjuvants Market Forecasts and Analysis - By Type
10.5.4 South and Central America Human Vaccine Adjuvants Market Forecasts and Analysis - By Route of Administration
10.5.5 South and Central America Human Vaccine Adjuvants Market Forecasts and Analysis - By Application
10.5.6 South and Central America Human Vaccine Adjuvants Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Human Vaccine Adjuvants Market
10.5.6.1.1 Brazil Human Vaccine Adjuvants Market by Type
10.5.6.1.2 Brazil Human Vaccine Adjuvants Market by Route of Administration
10.5.6.1.3 Brazil Human Vaccine Adjuvants Market by Application
10.5.6.2 Argentina Human Vaccine Adjuvants Market
10.5.6.2.1 Argentina Human Vaccine Adjuvants Market by Type
10.5.6.2.2 Argentina Human Vaccine Adjuvants Market by Route of Administration
10.5.6.2.3 Argentina Human Vaccine Adjuvants Market by Application
10.5.6.3 Rest of South and Central America Human Vaccine Adjuvants Market
10.5.6.3.1 Rest of South and Central America Human Vaccine Adjuvants Market by Type
10.5.6.3.2 Rest of South and Central America Human Vaccine Adjuvants Market by Route of Administration
10.5.6.3.3 Rest of South and Central America Human Vaccine Adjuvants Market by Application
11. IMPACT OF COVID-19 PANDEMIC ON GLOBAL HUMAN VACCINE ADJUVANTS MARKET
11.1 North America
11.2 Europe
11.3 Asia-Pacific
11.4 Middle East and Africa
11.5 South and Central America
12. INDUSTRY LANDSCAPE
12.1. MERGERS AND ACQUISITIONS
12.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
12.3. NEW PRODUCT LAUNCHES
12.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
13. HUMAN VACCINE ADJUVANTS MARKET, KEY COMPANY PROFILES
13.1. GSK
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Products and Services
13.1.4. Financial Overview
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. CSL LIMITED
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Products and Services
13.2.4. Financial Overview
13.2.5. SWOT Analysis
13.2.6. Key Developments
13.3. BRENNTAG BIOSECTOR
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Products and Services
13.3.4. Financial Overview
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. SEPPIC
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Products and Services
13.4.4. Financial Overview
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. SPI PHARMA
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Products and Services
13.5.4. Financial Overview
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. NOVAVAX
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Products and Services
13.6.4. Financial Overview
13.6.5. SWOT Analysis
13.6.6. Key Developments
13.7. AVANTI POLAR LIPIDS
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Products and Services
13.7.4. Financial Overview
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. APHIOS CORPORATION
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Products and Services
13.8.4. Financial Overview
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. AGENUS
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Products and Services
13.9.4. Financial Overview
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. MERCK KGAA
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Products and Services
13.10.4. Financial Overview
13.10.5. SWOT Analysis
13.10.6. Key Developments
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
The List of Companies

1. GSK
2. CSL Limited
3. Brenntag Biosector
4. SEPPIC
5. SPI Pharma
6. Novavax
7. Avanti Polar Lipids
8. Aphios Corporation
9. Agenus
10. Invivogen
11. OZ Biosciences
12. VaxLiant LLC.
13. Vaxine Pty. Ltd.
14. Viscogel AB
15. Sergeant Adjuvants
TIPRE00020517
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking